Social Neuroscience,
Journal Year:
2016,
Volume and Issue:
13(1), P. 1 - 39
Published: Oct. 6, 2016
Multiple
disorders
once
jointly
conceived
as
"nervous
diseases"
became
segregated
by
the
distinct
institutional
traditions
forged
in
neurology
and
psychiatry.
As
a
result,
each
field
specialized
study
treatment
of
subset
such
conditions.
Here
we
propose
new
avenues
for
interdisciplinary
interaction
through
triangulation
both
fields
with
social
neuroscience.
To
this
end,
review
evidence
from
five
relevant
domains
(facial
emotion
recognition,
empathy,
theory
mind,
moral
cognition,
context
assessment),
highlighting
their
common
disturbances
across
neurological
psychiatric
conditions
discussing
multiple
pathophysiological
mechanisms.
Our
proposal
is
anchored
multidimensional
evidence,
including
behavioral,
neurocognitive,
genetic
findings.
From
clinical
perspective,
work
paves
way
dimensional
transdiagnostic
approaches,
pharmacological
treatments,
educational
innovations
rooted
combined
neuropsychiatric
training.
Research-wise,
it
fosters
models
brain
novel
platform
to
explore
interplay
cognitive
functions.
Finally,
identify
challenges
synergistic
framework.
Neural Plasticity,
Journal Year:
2021,
Volume and Issue:
2021, P. 1 - 14
Published: Aug. 19, 2021
Acupuncture
is
widely
recognized
as
a
potentially
effective
treatment
for
stroke
rehabilitation.
Researchers
in
this
area
are
actively
investigating
its
therapeutic
mechanisms.
Magnetic
resonance
imaging
(MRI),
noninvasive,
high
anatomical
resolution
technique,
has
been
employed
to
investigate
neuroplasticity
on
acupuncture
patients
from
system
level.
However,
there
no
review
the
mechanism
of
based
MRI.
Therefore,
we
aim
summarize
current
evidence
about
aspect
and
provide
useful
information
future
research.
After
searching
PubMed,
Web
Science,
Embase
databases,
24
human
five
animal
studies
were
identified.
This
focuses
possible
mechanisms
underlying
therapy
treating
by
regulating
brain
plasticity.
We
found
that
reorganizes
not
only
motor-related
network,
including
primary
motor
cortex
(M1),
premotor
cortex,
supplementary
(SMA),
frontoparietal
network
(LFPN
RFPN),
sensorimotor
(SMN),
well
default
mode
(aDMN
pDMN),
but
also
language-related
areas
inferior
frontal
gyrus
frontal,
temporal,
parietal,
occipital
lobes,
cognition-related
regions.
In
addition,
can
modulate
function
structural
plasticity
post-stroke,
which
may
be
linked
effect
acupuncture.
Neural Regeneration Research,
Journal Year:
2023,
Volume and Issue:
19(1), P. 16 - 21
Published: May 25, 2023
Type-B
monoamine
oxidase
inhibitors,
encompassing
selegiline,
rasagiline,
and
safinamide,
are
available
to
treat
Parkinson's
disease.
These
drugs
ameliorate
motor
symptoms
improve
fluctuation
in
the
advanced
stages
of
There
is
also
evidence
supporting
benefit
type-B
inhibitors
on
non-motor
disease,
such
as
mood
deflection,
cognitive
impairment,
sleep
disturbances,
fatigue.
Preclinical
studies
indicate
that
hold
a
strong
neuroprotective
potential
disease
other
neurodegenerative
diseases
for
reducing
oxidative
stress
stimulating
production
release
neurotrophic
factors,
particularly
glial
cell
line-derived
factor,
which
support
dopaminergic
neurons.
Besides,
safinamide
may
interfere
with
mechanisms,
counteracting
excessive
glutamate
overdrive
basal
ganglia
circuit
death
from
excitotoxicity.
Due
dual
mechanism
action,
new
generation
including
gaining
interest
neurological
pathologies,
many
preclinical
now
available.
The
fields
application
concern
epilepsy,
Duchenne
muscular
dystrophy,
multiple
sclerosis,
above
all,
ischemic
brain
injury.
purpose
this
review
investigate
clinical
pharmacology
beyond,
focusing
possible
future
therapeutic
applications.
Stroke,
Journal Year:
2023,
Volume and Issue:
54(10), P. 2500 - 2511
Published: Sept. 25, 2023
Evidence
of
efficacy
repetitive
transcranial
magnetic
stimulation
(rTMS)
for
stroke
recovery
is
hampered
by
an
unexplained
variability
reported
effect
sizes
and
insufficient
understanding
mechanisms
action.
We
aimed
to
(1)
briefly
summarize
evidence
efficacy,
(2)
identify
critical
factors
explain
the
variation
in
effects,
(3)
provide
mechanism-based
recommendations
future
trials.We
performed
a
systematic
review
literature
according
Cochrane
PRISMA
Protocols.
included
trials
with
≥10
patients
per
treatment
group.
classified
outcome
measures
International
Classification
Functioning,
Disability,
Health.
Meta-analysis
was
done
when
at
least
3
were
on
same
construct.
In
case
significant
summary
heterogeneity,
we
used
sensitivity
analyses
test
correlations
differences
between
found
individual
possible
modifiers
such
as
patient-,
stimulation-,
trial
characteristics.We
57
articles
(N=2595).
Funnel
plots
showed
no
publication
bias.
level
body
function
(upper
limb
synergies,
muscle
strength,
language
functioning,
global
cognitive
visual/spatial
inattention)
within
or
beyond
months
after
stroke.
also
activities.
subgroup
any
tested
modifier.Repetitive
holds
potential
benefit
range
motor
outcomes
stroke,
but
challenged
heterogeneity
across
many
small
sampled
trials.
propose
large
collection
patient
data
baseline
severity
brain
network
integrity
sufficiently
powered
analyses,
well
protocolized
time-locked
training
target
behavior.
Additional
neurophysiological
biomechanical
may
help
identifying
biomarkers
efficacy.URL:
https://www.gov;
Unique
identifier:
CRD42022300330.
Social Neuroscience,
Journal Year:
2016,
Volume and Issue:
13(1), P. 1 - 39
Published: Oct. 6, 2016
Multiple
disorders
once
jointly
conceived
as
"nervous
diseases"
became
segregated
by
the
distinct
institutional
traditions
forged
in
neurology
and
psychiatry.
As
a
result,
each
field
specialized
study
treatment
of
subset
such
conditions.
Here
we
propose
new
avenues
for
interdisciplinary
interaction
through
triangulation
both
fields
with
social
neuroscience.
To
this
end,
review
evidence
from
five
relevant
domains
(facial
emotion
recognition,
empathy,
theory
mind,
moral
cognition,
context
assessment),
highlighting
their
common
disturbances
across
neurological
psychiatric
conditions
discussing
multiple
pathophysiological
mechanisms.
Our
proposal
is
anchored
multidimensional
evidence,
including
behavioral,
neurocognitive,
genetic
findings.
From
clinical
perspective,
work
paves
way
dimensional
transdiagnostic
approaches,
pharmacological
treatments,
educational
innovations
rooted
combined
neuropsychiatric
training.
Research-wise,
it
fosters
models
brain
novel
platform
to
explore
interplay
cognitive
functions.
Finally,
identify
challenges
synergistic
framework.